Nuvectis Pharma's market cap is currently $154.52M. The company's EPS TTM is $-0.3; its P/E ratio is ―; Nuvectis Pharma is scheduled to report earnings on August 5, 2025, and the estimated EPS forecast is $-0.25. See an overview of income statement, balance sheet, and cash flow financials.
